ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 118

Polymorphonuclear Neutrophils and Regulatory T Lymphocytes (Treg) Cooperate to Sustain Treg Activity but This Interaction Is Altered in Rheumatoid Arthritis Patients

Maxime Batignes 1, François Santinon 1, Marie-Christophe Boissier 2, Patrice Decker 1 and Natacha Bessis1, 1Inserm UMR 1125, University of Paris 13, Sorbonne Paris Cité, Bobigny, France, 2Assistance Publique-Hôpitaux de Paris (AP-HP), Rheumatology Department, Avicenne Hospital, Bobigny, France

Meeting: 2019 ACR/ARP Annual Meeting

Keywords: neutrophils, pathogenesis and therapeutic targeting, Rheumatoid arthritis (RA), T-Regulatory Cells

  • Tweet
  • Email
  • Print
Session Information

Date: Sunday, November 10, 2019

Title: T Cell Biology & Targets in Autoimmune & Inflammatory Disease Poster

Session Type: Poster Session (Sunday)

Session Time: 9:00AM-11:00AM

Background/Purpose: Regulatory T cells (Treg) are necessary for immune homeostasis but are functionally deficient in inflammatory/autoimmune diseases such as rheumatoid arthritis (RA). On the other hand, polymorphonuclear neutrophils (PMN) are known for their proinflammatory properties and are highly recruited at inflammation sites such as RA joints. However, recent evidences show that PMN exert also immunoregulatory functions. We hypothesized that Treg/PMN interact and that this interaction is dysregulated in RA. We aimed at deciphering the phenotype and activity of both cells upon in vitro Treg/PMN co-cultures and characterized the mechanisms involved. Finally, we analyzed the fate of Treg/PMN interaction in RA patients.

Methods: Splenic mouse Treg and bone marrow PMN (C57BL/6 mice) as well as peripheral blood Treg and PMN of healthy donors and RA patients were freshly purified by magnetic sorting. Co-cultures were unstimulated or exposed to anti-CD3/anti-CD28 antibodies and/or LPS. CD4+FoxP3+ Treg (mouse and human), Ly6G+ (mouse) and CD66b+ (human) PMN were identified by flow cytometry. Cell activation was further studied by flow cytometry using antibodies against CD25, CTLA-4 (Treg) and CD11b, CD39, PD-L1 (PMN). Treg maintenance was evaluated as the frequency of FoxP3 expression among CD4+ cells, and cell proliferation by CFSE staining followed by flow cytometry analysis. In some case, co-cultures were performed using transwell or Tofacitinib (a JAK inhibitor). Cytokine levels were quantified in culture supernatants by ELISA. Collagen-induced arthritis (CIA) was induced by immunization with type II collagen in complete Freund’s adjuvant.

Results: Upon co-culture in vitro with PMN, Treg proliferated, showed increased maintenance of FoxP3 expression and up-regulated CTLA-4 as well as CD25 compared to Treg cultured alone, only when both Treg and PMN were stimulated. Reciprocally, upon co-culture with Treg, PMN were activated and expressed regulatory molecules, as evidenced by CD11b, CD39 and PD-L1 up-regulation, as compared to PMN cultured alone, when both cell types were stimulated. The co-culture led to higher secretion of MIP-2/IL-8, IL-6 and IL-17. All these effects were abrogated when co-cultures were done using transwell or when blocking JAK-STAT signalling. Most importantly, PMN sustain Treg suppressive effect on effector (CD4+FoxP3–) T cells (inhibition of cell proliferation). Similar results were observed in co-cultures of PMN/Treg isolated from mice (both naïve and CIA mice) and healthy donors. However, and importantly, we found out that PMN from RA patients were unable to increase CTLA-4 expression on Treg in co-culture, CTLA-4 being involved in Treg suppressive activity.

Conclusion: Our results reveal the existence of a new link between Treg and PMN, leading to an activation of both cell types and a more suppressive phenotype in healthy conditions. Although cell contacts are clearly required, soluble mediators are also involved and probably as a second signal. This is the first demonstration of an effect of PMN on Treg phenotype. In RA patients, we evidenced a defect in this Treg/PMN cross-talk. This Treg/PMN interaction might unveil new therapeutic targets against RA.


Disclosure: M. Batignes, None; F. Santinon, None; M. Boissier, None; P. Decker, None; N. Bessis, None.

To cite this abstract in AMA style:

Batignes M, Santinon F, Boissier M, Decker P, Bessis N. Polymorphonuclear Neutrophils and Regulatory T Lymphocytes (Treg) Cooperate to Sustain Treg Activity but This Interaction Is Altered in Rheumatoid Arthritis Patients [abstract]. Arthritis Rheumatol. 2019; 71 (suppl 10). https://acrabstracts.org/abstract/polymorphonuclear-neutrophils-and-regulatory-t-lymphocytes-treg-cooperate-to-sustain-treg-activity-but-this-interaction-is-altered-in-rheumatoid-arthritis-patients/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2019 ACR/ARP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/polymorphonuclear-neutrophils-and-regulatory-t-lymphocytes-treg-cooperate-to-sustain-treg-activity-but-this-interaction-is-altered-in-rheumatoid-arthritis-patients/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology